Trial Details
UNKNOWNBasic Information
| Clinical ID | c1197 |
|---|---|
| Identifier | NCT05427942 |
| Trial Title | Yuflyma® (Adalimumab), Patient Experience After Switching |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Rheumatoid Arthritis|Ankylosing Spondylarthritis|Axial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis|Psoriatic Arthritis|Crohn Disease|Ulcerative Colitis |
| Interventions | DRUG: Adalimumab |
Participant Information
| Sponsor | Celltrion HealthCare France |
|---|---|
| City | Marseille |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2022-06-03 |
|---|---|
| Primary Completion Date | 2022-12-31 |
| Completion Date | 2023-03-01 |